In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

Consuming more ultraprocessed foods could mean a greater risk for type 2 diabetes, according to new research. Experts share ...

A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...